homocholine has been researched along with Chagas Disease in 1 studies
*Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afroudakis, P; Alunda, JM; Barrias, E; Bifeld, E; Calogeropoulou, T; Clos, J; Cordeiro da Silva, A; Corral, MJ; de Souza, W; Eick, J; Ellinger, B; Fotopoulou, T; Fragiadaki, I; Georgikopoulou, K; Gul, S; Jiménez-Antón, MD; Kuzikov, M; Luelmo, S; Magoulas, GE; Nevado, PT; Pöhner, I; Prousis, KC; Roussaki, M; Santarem, N; Scoulica, E; Torrado, JJ; Wade, RC | 1 |
1 other study(ies) available for homocholine and Chagas Disease
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of antiparasitic dinitroaniline-ether phospholipid hybrids.
Topics: Antiparasitic Agents; Antiprotozoal Agents; Chagas Disease; Choline; Humans; Phospholipid Ethers; Trypanosoma cruzi | 2023 |